1.Sun X, Xiao Z, Chen G, Han Z, Liu Y, Zhang C, Sun Y, Song Y, Wang K, Fang F, Wang X, Lin Y, Xu L, Shao L, Li J, Cheng Z*, Gambhir SS*, Shen B*. A PET imaging approach for determining EGFR mutation status for improved lung cancer patient management. Sci Transl Med. 2018 Mar 7;10(431).
2.Yige Sun#, Jie Yang#, Yingbo Li#, Jing Luo, Jiemei Sun, Daoshuang Li, Yuchen Wang, Kai Wang, Lili Yang, Lina Wu* and Xilin Sun*. Single low-dose INC280-loaded theranostic nanoparticles achieve multirooted delivery for MET-targeted primary and liver metastatic NSCLC. Molecular Cancer (2022)21:212.
3.Rong A, Haoyu Wang, Chaoqun Nie, Zhaoguo Han, Meifang Zhou, Olagbaju Oluwatosin Atinuke, Kaiqi Wang, Xiance Wang, Shuang Liu, Jingshi Zhao, Wenju Qiao, Xiaohong Sun, Lina Wu, Xilin Sun*. Glycerol-weighted chemical exchange saturation transfer nanoprobes allow 19F/1H dual-modality magnetic resonance imaging-guided cancer radiotherapy. Nature communications.(2023)14,6644.
4.Zhen Quan#, Zhaoguo Han#, Yang Yang, Jiannan Wang, Hui Wang, Lili Yang, Rong A, Xinxin Hu, Jing Wang, Xiaona Li, Xiaoqian Li, Hong Yu, Wei Chen, Kai Wang, Xilin Sun*. Noninvasive Monitoring of Immunotherapy in Lung Cancer by Lymphocyte Activation Gene 3 PET Imaging of Tumor-Infiltrating Lymphocytes. Journal of Nuclear Medicine. 2024, 65 (1) 25-32.
5.Zhaoguo Han#, Yadi Xiao#, Kai Wang, Ji Yan, Zunyu Xiao, Fang Fang, Zhongnan Jin, Yang Liu, Xilin Sun*, Baozhong Shen*.Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non–Small Cell Lung Cancer. Journal of nuclear medicine, 2018 Nov;59(11):1686-1691.